d-Cycloserine, a putative cognitive enhancer, facilitates activation of the N-methyl-d-aspartate receptor-ionophore complex in Alzheimer brain-Reference-Cited by-同舟云学术

d-Cycloserine, a putative cognitive enhancer, facilitates activation of the N-methyl-d-aspartate receptor-ionophore complex in Alzheimer brain

Published:1991-11 Issue:2 Volume:565 Page:345-348
ISSN:0006-8993
Container-title:Brain Research
language:en
Short-container-title:Brain Research

Author:

Chessell Ian P.,Procter Andrew W.,Francis Paul T.,Bowen David M.

Publisher

Elsevier BV

Subject

Developmental Biology,Neurology (clinical),Molecular Biology,General Neuroscience

Reference33 articles.

1. Activity of 5,7-dichlorokynurenic acid, a potent antagonist at the N-methyl-d-aspartate receptor-associated glycine binding site;Baron;Mol. Pharmacol.,1990

2. Treatment of Alzheimer's disease: molecular pathology versus neurotransmitter-based therapy;Bowen;Br. J. Psychiatry,1990

3. Circumscribed changes of the cerebral cortex in neuropsychiatric disorders of later life;Bowen,1989

4. Positron emission tomography in aging and dementias: effect of cerebral atrophy;Chawluk;J. Nucl. Med.,1987

5. A topological model of the NMDA-glycine receptor model;Cordi;J. Recept. Res.,1990

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-NMDA and Anti-AMPA Receptor Antibodies in Central Disorders: Preclinical Approaches to Assess Their Pathological Role and Translatability to Clinic;International Journal of Molecular Sciences;2023-10-05

2. Involvement of Cholinergic, Adrenergic, and Glutamatergic Network Modulation with Cognitive Dysfunction in Alzheimer’s Disease;International Journal of Molecular Sciences;2021-02-25

3. Antimicrobial therapy and the potential mechanisms in Alzheimer’s disease;Neuroscience Letters;2021-01

4. Targeted Treatment of Individuals With Psychosis Carrying a Copy Number Variant Containing a Genomic Triplication of the Glycine Decarboxylase Gene;Biological Psychiatry;2019-10

5. Exploiting the therapeutic potential of ready-to-use drugs: Repurposing antibiotics against amyloid aggregation in neurodegenerative diseases;Progress in Neurobiology;2018-03